JY
PMCB icon

Jeff Yass’s PharmaCyte Biotech PMCB Stock Holding History

Jeff Yass’s Portfolio PMCB Stock Details PMCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-39,900
Closed -$116K – 12890
2023
Q1 		$116K Buy
39,900
+3,000
+8% +$8.82K ﹤0.01% 11164
2022
Q4 		$108K Sell
36,900
-35,900
-49% -$103K ﹤0.01% 10899
2022
Q3 		$175K Sell
72,800
-80,400
-52% -$203K ﹤0.01% 11030
2022
Q2 		$346K Buy
+153,200
New +$335K ﹤0.01% 9188
2022
Q1 		– Sell
-28,500
Closed -$71K – 13750
2021
Q4 		$71K Buy
+28,500
New +$78.5K ﹤0.01% 12368

Other funds holding PMCB

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Jeff Yass's PMCB Position: Q2 2026 in Review

Jeff Yass opened a new position in PharmaCyte Biotech (PMCB) in Q2 2026: 44,853 shares worth $34.5K. The stake represents ﹤0.01% of the portfolio and ranks #12930 among its holdings. This is a return to the name: Jeff Yass previously reported a position in PMCB as recently as Q2 2025.

Jeff Yass first reported a position in PMCB in Q1 2022 and has held it in 12 quarters since. The position peaked at $311K in Q1 2023. 28 funds tracked by Wall St. Rank hold PMCB as of Q2 2026.

  • Jeff Yass held 44,853 shares of PharmaCyte Biotech worth $34.5K as of Q2 2026.
  • PharmaCyte Biotech was a new Jeff Yass position in Q2 2026.
  • PharmaCyte Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12930 holding.
  • Jeff Yass first reported a position in PharmaCyte Biotech in Q1 2022 and has held it in 12 quarters since.
  • Jeff Yass's PharmaCyte Biotech position peaked at $311K in Q1 2023.
  • 28 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.